📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Egr2 and 3 maintain anti-tumour responses of exhausted tumour infiltrating CD8 + T cells. (2023)

First Author: Symonds ALJ

Attributed to: Investigation of the early growth response gene (Egr) 2 and 3 mediated regulatory programme in T cells funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1007/s00262-022-03319-w

PubMed Identifier: 36342511

Publication URI: http://europepmc.org/abstract/MED/36342511

Type: Journal Article/Review

Volume: 72

Parent Publication: Cancer immunology, immunotherapy : CII

Issue: 5

ISSN: 0340-7004